The Global Isothermal Nucleic Acid Amplification Technology Market reached about US$ 4.53 billion in 2023 and is projected to grow to around US$ 8.91 billion by 2031. This represents a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.

The growth is fueled by the rising use of rapid molecular diagnostic tools, an increase in infectious and chronic disease cases, and improvements in point-of-care testing technologies. The benefits of this technology, including faster results, simpler operations without thermal cycling, and suitability for resource-limited settings, are leading to its wider use in healthcare, environmental monitoring, and food safety. Additionally, ongoing innovations in assay development and the integration of INAAT with portable diagnostic devices are likely to boost market growth further.

Get a Free Sample PDF of This Report: https://www.datamintelligence.com/download-sample/isothermal-nucleic-acid-amplification-technology-market?ram

Key Developments:

United States: Isothermal Nucleic Acid Amplification Technology Market

- October 2025: Thermo Fisher Scientific launched a portable INAAT platform that includes microfluidic cartridges and smartphone-based detection. This will allow real-time pathogen identification in field and clinical settings.

- September 2025: Abbott Laboratories introduced upgraded loop-mediated isothermal amplification (LAMP) assays under its ID NOW platform, which improves detection accuracy for influenza and RSV and enhances point-of-care testing reliability.

- August 2025: Hologic acquired a U.S.-based biotechnology firm that specializes in enzymatic amplification chemistry to expand its molecular diagnostics beyond PCR-based systems.

- July 2025: Bio-Rad Laboratories partnered with an AI-focused health startup to incorporate machine learning algorithms into INAAT workflow systems. This aims to improve predictive analysis and reduce false negatives in disease screening.

Japan: Isothermal Nucleic Acid Amplification Technology Market

- October 2025: Sysmex Corporation introduced an automated INAAT diagnostic device designed for decentralized healthcare facilities to meet the increasing demand for rapid nucleic acid testing in rural areas.

- September 2025: Hitachi High-Tech Corporation launched a manufacturing system for mass-producing INAAT reagents, focusing on better cost efficiency and preparedness for disease outbreaks.

- August 2025: Canon Medical Systems teamed up with research institutions to apply INAAT technology for biosurveillance and early detection of zoonotic viruses.

- July 2025: Fujifilm Holdings Corporation enhanced its molecular diagnostic capabilities by introducing a next-generation INAAT kit that allows high-sensitivity detection of hepatitis and tuberculosis pathogens.

Recent Mergers and Acquisitions (M&A):

United States: Isothermal Nucleic Acid Amplification Technology Market

- October 2025: Thermo Fisher Scientific acquired a molecular testing startup that focuses on microfluidic chip miniaturization for portable INAAT systems.

- August 2025: Abbott Laboratories formed a joint venture with a diagnostics software company to develop AI-driven cloud connectivity for its molecular testing portfolio, including INAAT platforms.

Japan: Isothermal Nucleic Acid Amplification Technology Market

- October 2025: Sysmex Corporation merged with a local biotech company to co-develop next-generation INAAT reagents that use CRISPR-based precision amplification for faster genetic testing.

- August 2025: Fujifilm Holdings partnered with Toshiba Corporation to incorporate INAAT assay modules into multifunction diagnostic platforms, enhancing flexibility for hospitals and clinics.

Key Players:

bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited, and Thermo Fisher Scientific.

Market Dynamics and Growth Drivers:

- Growing Demand for Point-of-Care Diagnostics: INAAT offers quick, portable, and affordable molecular diagnostics, making it suitable for point-of-care settings, especially in remote areas.

- Improvements in Molecular Diagnostics: Innovations in INAAT methods, including Loop-mediated Isothermal Amplification (LAMP) and Recombinase Polymerase Amplification (RPA), are increasing the sensitivity and specificity of nucleic acid detection.

- Rising Incidence of Infectious Diseases: More cases of viral and bacterial infections are driving the need for quick diagnostics like INAAT.

- Supportive Government Initiatives: Investments and programs aimed at enhancing healthcare infrastructure and diagnostic capabilities are aiding the growth of the INAAT market.

- Growth in Research and Development Activities: Continuous research and development are leading to new INAAT platforms and assays, widening the scope of this technology's applications.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=isothermal-nucleic-acid-amplification-technology-market?ram

Growth Forecast Projected:

The Global Isothermal Nucleic Acid Amplification Technology Market is expected to grow significantly from 2024 to 2031. In 2023, the market is expanding at a steady rate, and with key players adopting new strategies, it is projected to rise over the coming years.

Research Process:

The research for the Global Isothermal Nucleic Acid Amplification Technology Market report used both primary and secondary data sources. Various factors affecting the industry were examined, including government regulations, market conditions, competition, historical data, technological advancements, new developments, as well as market risks and challenges.

Key Segments:

- By Product Type: Instruments, Reagents

- By Technology: Nucleic Acid Sequence-based Amplification (NASBA), Single Primer Isothermal Amplification (SPIA), Nicking Enzyme Amplification Reaction (NEAR), Helicase-dependent Amplification (HDA), Transcription Mediated Amplification (TMA), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Others

- By Application: Infectious Diseases Diagnostics, Blood Screening, Cancer Research, Others

- By End User: Hospitals, Diagnostic Laboratories, Research Laboratories, Others

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.